Search for other papers by Cecilia Lundin in
Google Scholar
PubMed
Search for other papers by Agota Malmborg in
Google Scholar
PubMed
Search for other papers by Julia Slezak in
Google Scholar
PubMed
Search for other papers by Kristina Gemzell Danielsson in
Google Scholar
PubMed
Search for other papers by Marie Bixo in
Google Scholar
PubMed
Search for other papers by Hanna Bengtsdotter in
Google Scholar
PubMed
Search for other papers by Lena Marions in
Google Scholar
PubMed
Search for other papers by Ingela Lindh in
Google Scholar
PubMed
Search for other papers by Elvar Theodorsson in
Google Scholar
PubMed
Search for other papers by Mats Hammar in
Google Scholar
PubMed
Search for other papers by Inger Sundström-Poromaa in
Google Scholar
PubMed
COC users report decreased sexual desire ( 2 ). At present, despite the bulk of literature, only two randomised placebo-controlled trials have investigated the causal influence of COCs on sexual function ( 3 , 4 ). Both of these studies evaluated a
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Search for other papers by Magda Lambaa Altinok in
Google Scholar
PubMed
Search for other papers by Pernille Ravn in
Google Scholar
PubMed
Search for other papers by Kurt Bjerregaard Stage in
Google Scholar
PubMed
Search for other papers by Kurt Højlund in
Google Scholar
PubMed
Search for other papers by Marianne Andersen in
Google Scholar
PubMed
not aware of previous studies testing this hypothesis. The aim of the present study was to investigate the effect of 12-week escitalopram vs placebo treatment on adrenal activity, mental health, metabolic risk and PCOS phenotype in overweight women
Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Christian Høst in
Google Scholar
PubMed
Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Search for other papers by Mogens Erlandsen in
Google Scholar
PubMed
Search for other papers by Kristian A Groth in
Google Scholar
PubMed
Search for other papers by Kurt Kristensen in
Google Scholar
PubMed
Search for other papers by Anne Grethe Jurik in
Google Scholar
PubMed
Search for other papers by Niels H Birkebæk in
Google Scholar
PubMed
Department of Molecular Medicine, Aarhus University Hospital, Aarhus N, Denmark
Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
( 20 ). The present study is the first randomized placebo-controlled study to investigate the effects of testosterone treatment on insulin sensitivity, body composition, muscle strength and maximal oxygen uptake in patients with KS using gold standard
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
-blinded, placebo-controlled intervention study, we investigate in detail the effect of physiological doses of testosterone on the capacity of the TF and contact activation pathways of coagulation and related coagulation factors and inhibitors in opioid-treated men
Search for other papers by Niels B Dalsgaard in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Lærke S Gasbjerg in
Google Scholar
PubMed
Search for other papers by Laura S Hansen in
Google Scholar
PubMed
Search for other papers by Dennis S Nielsen in
Google Scholar
PubMed
Search for other papers by Torben S Rasmussen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
impact of acarbose on host GM and health ( 8 , 13 , 14 , 15 ). Here, using faecal samples collected in a previously published randomised double-blind, placebo-controlled clinical trial ( 7 , 16 ), we investigated the effects of a 2-week treatment
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
Search for other papers by Chiara Jongerius in
Google Scholar
PubMed
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
Search for other papers by Marij A Hillen in
Google Scholar
PubMed
Amsterdam Public Health, Quality of Care, Amsterdam, The Netherlands
Search for other papers by Ellen M A Smets in
Google Scholar
PubMed
Search for other papers by Mathijs J Mol in
Google Scholar
PubMed
Search for other papers by Eefje S Kooij in
Google Scholar
PubMed
Search for other papers by Maria A de Nood in
Google Scholar
PubMed
Search for other papers by Edwin S Dalmaijer in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Johannes A Romijn in
Google Scholar
PubMed
Department of Rare Disorders and Disabilities, Oslo University Hospital, NevSom, Oslo, Norway
University of Oslo, Norwegian Centre for Mental Disorders Research (NORMENT) and KG Jebsen Centre for Neurodevelopmental Disorders, Oslo, Norway
Search for other papers by Daniel S Quintana in
Google Scholar
PubMed
-registered, placebo-controlled, randomized experiment, in which we compared the effects of intranasal administration of oxytocin and placebo on the gaze of healthy volunteers toward the eye region of a physician. We expected oxytocin to increase the gaze toward the
Search for other papers by Sarah Zaheer in
Google Scholar
PubMed
Search for other papers by Kayla Meyer in
Google Scholar
PubMed
Search for other papers by Rebecca Easly in
Google Scholar
PubMed
Search for other papers by Omar Bayomy in
Google Scholar
PubMed
Search for other papers by Janet Leung in
Google Scholar
PubMed
Search for other papers by Andrew W Koefoed in
Google Scholar
PubMed
Search for other papers by Mahyar Heydarpour in
Google Scholar
PubMed
Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Search for other papers by Roy Freeman in
Google Scholar
PubMed
Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA
Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Gail K Adler in
Google Scholar
PubMed
examining the effect of glucocorticoids vs placebo on sclerostin. This study demonstrated a significant decrease in serum sclerostin with a high (30 mg/day), but not low (7.5 mg/day), dose of prednisolone given over 2 weeks in healthy young men ( 28 ). These
Search for other papers by Kyoungjune Pak in
Google Scholar
PubMed
Search for other papers by Seongho Seo in
Google Scholar
PubMed
Search for other papers by Myung Jun Lee in
Google Scholar
PubMed
Search for other papers by Keunyoung Kim in
Google Scholar
PubMed
Search for other papers by Sunghwan Suh in
Google Scholar
PubMed
Search for other papers by Hyung-Jun Im in
Google Scholar
PubMed
Search for other papers by In Joo Kim in
Google Scholar
PubMed
calculated as follows: weight/height -2 . Bilateral antecubital veins were cannulated: one for blood sampling and for injection of 18 F-FP-CIT and the other for low or high-dose glucose or placebo infusions. The subjects were blinded and randomly assigned
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
The study was a single-centre, randomised, double-blind, placebo-controlled, double-dummy, three-arm, parallel-group study conducted from December 2019 to June 2021 at Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen
Search for other papers by Ermina Bach in
Google Scholar
PubMed
Search for other papers by Niels Møller in
Google Scholar
PubMed
Search for other papers by Jens Otto L Jørgensen in
Google Scholar
PubMed
Search for other papers by Mads Buhl in
Google Scholar
PubMed
Search for other papers by Holger Jon Møller in
Google Scholar
PubMed
. In two placebo-controlled human trials we, therefore, aimed (1) to compare the effects of LPS on levels of sCD163 in hypopituitary patients (HP) (in the absence of pituitary stress hormone responses) and control subjects (CTR) by infusing LPS